In January 2025, Kevin Saunders wasn’t too worried that the Trump administration was coming for his Human Immunodeficiency Virus research at Duke University. The administration had stalled National Institutes of Health meetings to review grant proposals, effectively freezing funding distribution and sending shockwaves through the scientific community. But Saunders, as associate director of the Duke Human Vaccine Institute, was among the leaders…